LENZ Therapeutics, Inc.

Direct answer

LENZ Therapeutics, Inc. is publicly traded on NASDAQ under the ticker LENZ.

LENZ Therapeutics, Inc. is a biopharmaceutical firm whose primary mission involves the advancement and commercialization of new treatments designed to enhance vision for individuals in the United States. The company's portfolio features two investigational products, LNZ100 and LNZ101, both of which are currently undergoing late-stage Phase III clinical trials as potential solutions for presbyopia. Corporate...

Can you invest in LENZ Therapeutics, Inc.?

Yes. LENZ Therapeutics, Inc. is publicly traded on NASDAQ under the ticker LENZ.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for LENZ Therapeutics, Inc.

Detailed equity research is provided by MarketSnap.